Research by University College London shows the anti-obesity drug semaglutide reduces the risk of heart attacks and other major cardiovascular problems, regardless of how much weight patients lose while taking it. Published in The Lancet, the study analysed data from 17,604 adults aged 45 and over who were overweight and living with cardiovascular disease. Participants … Continue reading Obesity drug cuts heart attack risk regardless of weight loss